LCTX
Lineage Cell Therapeutics Inc
Price:  
1.01 
USD
Volume:  
720,678.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LCTX Stock Forecast & Price Target

LCTX Stock Price Forecast

The average stock forecast for Lineage Cell Therapeutics Inc (LCTX) in the next 12 months is 5.61 USD. This price target corresponds to an upside of 410.00%. The range of stock forecasts for LCTX is 3.03 - 9.45 USD. Based on the ratings of 13 analysts, the consensus recommendation for LCTX is BUY.
Target Low Average Median High
Price (USD) 3.03 5.61 4.59 9.45
Upside 175.45% 410.00% 317.27% 759.09%

Recommendation Trends

The latest consensus rating for LCTX is "BUY". This is the average recommendation of 13 analysts: 0 strong sell, 0 sell, 2 hold, 8 buy, 3 strong buy. In the previous period, 13 analysts also majorly recommmended "BUY" for LCTX.

LCTX Financial Stock Forecast

Revenue This Year
8.70M
-40.23%
from 14.56M
Revenue Next Year
6.79M
-21.97%
from 8.70M
EPS This Year
-0.07
-71.98%
from -0.25
EPS Next Year
-0.13
78.57%
from -0.07